切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Xanthine oxidoreductases - HCV polymerase - dCTP Pyrophosphatases - Insulin and Insulin-like Receptors

10 件产品

每页
清除全部
  1. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  2. Allopurinol
    A8360 Allopurinol
    中文名: 别嘌醇
    Target: Xanthine oxidoreductases
    Summary: 黄嘌呤氧化酶抑制剂
      ≥5.15 mg/mL
      insoluble in H2O
  3. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  4. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  5. Triptonide
    A3892 Triptonide
    中文名: 雷公藤内酯酮
    Target: dCTP Pyrophosphatases
    Summary: dCTP焦磷酸酶抑制剂
      ≥16.35 mg/mL
      insoluble in H2O
  6. PSI-7977
    A3738 PSI-7977
    中文名: 索非布韦,索氟布韦
    Target: HCV polymerase
    Summary: 慢性丙型肝炎病毒(HCV)感染的抗病毒剂
      ≥183 mg/mL
      insoluble in H2O
  7. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  8. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O
  9. VX-222 (VCH-222, Lomibuvir)
    A4032 VX-222 (VCH-222, Lomibuvir)
    Target: HCV polymerase
    Summary: HCV RNA聚合酶抑制剂
      ≥44.6 mg/mL
      insoluble in H2O
  10. PSI-6206
    A8189 PSI-6206
     3 Citation
    Target: HCV polymerase
    Summary: HCV RNA聚合酶抑制剂
      ≥13.1 mg/mL
      ≥48.7 mg/mL

10 件产品

每页